Group One Trading, L.P. Moderna, Inc. Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Moderna, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 444,438 shares of MRNA stock, worth $12.3 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

444,438

Previous 251,904 76.43%

Holding current value

$12.3 Million

Previous $10.5 Million 20.29%

% of portfolio

0.57%

Previous 0.39%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$28.35 - $47.53 $5.46 Million - $9.15 Million	192,534 Added 76.43%	444,438 $12.6 Million
Q4 2024 Feb 14, 2025	BUY	$36.85 - $63.93 $2.76 Million - $4.78 Million	74,831 Added 42.26%	251,904 $10.5 Million
Q3 2024 Nov 14, 2024	BUY	$63.64 - $125.14 $4.48 Million - $8.8 Million	70,323 Added 65.88%	177,073 $11.8 Million
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $7.46 Million - $12.3 Million	73,667 Added 222.67%	106,750 $12.7 Million
Q1 2024 May 10, 2024	SELL	$85.37 - $115.44 $1.86 Million - $2.51 Million	-21,750 Reduced 39.67%	33,083 $3.53 Million
Q4 2023 Feb 14, 2024	SELL	$69.51 - $104.43 $2.32 Million - $3.48 Million	-33,330 Reduced 37.8%	54,833 $5.45 Million
Q3 2023 Nov 09, 2023	SELL	$96.41 - $126.61 $1.89 Million - $2.48 Million	-19,598 Reduced 18.19%	88,163 $9.11 Million
Q2 2023 Aug 09, 2023	BUY	$118.5 - $160.53 $5.51 Million - $7.46 Million	46,469 Added 75.82%	107,761 $13.1 Million
Q1 2023 May 12, 2023	SELL	$135.66 - $197.02 $19.9 Million - $28.9 Million	-146,604 Reduced 70.52%	61,292 $9.41 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $1.4 Million - $2.48 Million	11,806 Added 6.02%	207,896 $37.3 Million
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $6.18 Million - $10.2 Million	52,331 Added 36.4%	196,090 $23.2 Million
Q2 2022 Aug 11, 2022	BUY	$117.13 - $176.59 $9.18 Million - $13.8 Million	78,361 Added 119.82%	143,759 $20.5 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $8.27 Million - $15.4 Million	65,398 New	65,398 $11.3 Million
Q2 2021 Aug 10, 2021	SELL	$129.91 - $234.98 $34.2 Million - $61.8 Million	-262,902 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$109.18 - $185.98 $18.9 Million - $32.2 Million	173,091 Added 192.73%	262,902 $34.4 Million
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $1.66 Million - $4.29 Million	25,270 Added 39.15%	89,811 $9.38 Million
Q3 2020 Nov 12, 2020	SELL	$54.34 - $94.85 $12.3 Million - $21.4 Million	-226,119 Reduced 77.8%	64,541 $4.57 Million
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $3.72 Million - $10 Million	125,369 Added 75.85%	290,660 $18.7 Million
Q1 2020 May 13, 2020	BUY	$17.78 - $31.58 $2.94 Million - $5.22 Million	165,291 New	165,291 $4.95 Million
Q4 2019 Feb 10, 2020	SELL	$13.93 - $21.28 $1.2 Million - $1.83 Million	-85,799 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$12.26 - $18.07 $640,094 - $943,434	52,210 Added 155.44%	85,799 $1.37 Million
Q2 2019 Aug 09, 2019	BUY	$13.7 - $28.34 $460,169 - $951,912	33,589 New	33,589 $492,000
Q1 2019 May 13, 2019	SELL	$14.45 - $23.7 $332 - $545	-23 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$13.52 - $18.8 $310 - $432	23 New	23 $0

Others Institutions Holding MRNA

# of Institutions

875

Shares Held

255M

Call Options Held

24M

Put Options Held

31.3M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $10.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Moderna, Inc. Transaction History